Vaccines for HIV: A new design strategy

HIV has eluded vaccine-makers for thirty years, in part due to the virus' extreme ability to mutate. Physical scientists and clinical virologists from the Massachusetts Institute of Technology (MIT) and the Ragon Institute ...

New HIV model suggests killer T cell for vaccine

Limited success in modelling the behaviour of the complex, unusual and unpredictable HIV virus has slowed efforts to develop an effective vaccine to prevent AIDS.

Biochemists discover mechanism that helps flu viruses evolve

Influenza viruses mutate rapidly, which is why flu vaccines have to be redesigned every year. A new study from MIT sheds light on just how these viruses evolve so quickly, and offers a potential way to slow them down.

HIV's sugar coating offers new vaccine approach

(PhysOrg.com) -- Oxford research suggests the chains of sugar molecules, or carbohydrates, that cover the outside of the highly variable HIV virus remain constant, are different from those found on human cells, and could ...

Zika and yellow fever—vaccines without eggs

A team led by researchers from the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg is developing methods with which viruses for vaccines can be replicated in significantly higher concentrations ...

page 2 from 6